Syreon Research Institute is supported by an economic modelling division with extensive experience in economic evaluation of healthcare interventions and made up of members with a full understanding of the challenges of modelling, data management, data and statistical analysis. Economic modelling permits sophisticated sensitivity and scenario analyses to assess principal influential factors, "what if" scenarios in healthcare, and estimation of the impact of potential risks of interventions on projected costs and outcomes. Methods are applied in order to predict and adjust future demand for healthcare, to examine demographic factors which relate to health, to understand patient health-related behaviour and to optimize healthcare delivery. The team has the in-depth understanding and the breadth of know-how essential for modelling cost-effectiveness and budget impact in a wide range of therapeutic areas, especially oncology, diabetes, mental disorders, transplantation, women’s health, musculoskeletal disorders, orphan treatments and preventive technologies. The developed economic models serve as supportive tools to global value assessments, strategic pricing recommendations and policy decisions.
|Division of Health Economic Modelling|